IMBRUVICA® (ibrutinib) Available For Prescription Order
Onco360 has been selected to the extremely limited distribution network of
Specialty Pharmacies for IMBRUVICA (ibrutinib).
Ordering IMBRUVICA From Onco360
3 easy ways to order IMBRUVICA.
e-Prescribe to Onco360 in Great Neck, NY 11021, or NPI# 1679618151 under the retail tab in your EMR/EHR or standalone e-prescribing application.
IMBRUVICA (ibrutinib) has been approved by the FDA for the four following indications and is available for prescription order through Onco360.
|APPROVED INDICATIONS1||RECOMMENDED DOSAGE2|
|Chronic lymphocytic leukemia (CLL) patients||420 mg (three 140 mg capsules) orally once daily|
|CLL patients with 17p deletion||420 mg (three 140 mg capsules) orally once daily|
|Waldenström’s macroglobulinemia (WM) patients||420 mg (three 140 mg capsules) orally once daily|
|Mantle cell lymphoma (MCL) patients who have received
at least one prior treatment
|560 mg (four 140 mg capsules) orally once daily|
For more information about IMBRUVICA, please visit IMBRUVICA.com.
- Imbruvica Prescribing Information
All rights in the product names, trade names, or logos of all third-party products, whether or not appearing with the registered trademark symbol, belong exclusively to their respective owners.